BrainStorm
The Menopause-Alzheimer's Connection: Why Timing Matters for Women's Brain Health with Dr. Rachel Buckley (part 2)
The Menopause-Alzheimer's Connection: Why Timing Matters for Women's Brain Health with Dr. Rachel Buckley (part 2)
Dr. Rachel Buckley discusses the critical link between menopause and Alzheimer's risk in women with BrainStorm host Meryl Comer. Dr. Buckley explains that early menopause can be associated with faster cognitive decline and higher tau levels in the brain. She emphasizes the importance of timing for hormone replacement therapy and how estrogen plays a vital role in brain health through receptors that regulate communication between brain regions and mood. Dr. Buckley advocates for proactive conversations with doctors starting at age 40, midlife cognitive checkups around age 55, and better sex-specific reporting in clinical trials, noting that recent Alzheimer's treatments showed dramatically different results in men (42% benefit) versus women (12% benefit). As leader of a Welcome LEAP research team, she's working to cut women's lifetime Alzheimer's risk in half within three years, representing a new wave of prevention-focused research that coincides with the critical menopause transition period. This is a must listen episode!
About This Episode
Dr. Rachel Buckley discusses the critical link between menopause and Alzheimer's risk in women with BrainStorm host Meryl Comer. Dr. Buckley explains that early menopause can be associated with faster cognitive decline and higher tau levels in the brain. She emphasizes the importance of timing for hormone replacement therapy and how estrogen plays a vital role in brain health through receptors that regulate communication between brain regions and mood. Dr. Buckley advocates for proactive conversations with doctors starting at age 40, midlife cognitive checkups around age 55, and better sex-specific reporting in clinical trials, noting that recent Alzheimer's treatments showed dramatically different results in men (42% benefit) versus women (12% benefit). As leader of a Welcome LEAP research team, she's working to cut women's lifetime Alzheimer's risk in half within three years, representing a new wave of prevention-focused research that coincides with the critical menopause transition period. This is a must listen episode!